MoneyWorks4Me

FDC launches oral suspension of Favipiravir

12 Jul 2021 Evaluate

FDC has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country. This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India. Convenient loading dosage of the oral suspension helps reduce dosage frequency.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..